Cargando…

Ghrelin in Diabetes and Metabolic Syndrome

Metabolic syndrome is a cluster of related risk factors for cardiovascular disease, type 2 diabetes and liver disease. Obesity, which has become a global public health problem, is one of the major risk factors for development of metabolic syndrome and type 2 diabetes. Obesity is a complex disease, c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pulkkinen, Leena, Ukkola, Olavi, Kolehmainen, Marjukka, Uusitupa, Matti
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911592/
https://www.ncbi.nlm.nih.gov/pubmed/20700400
http://dx.doi.org/10.1155/2010/248948
_version_ 1782184481618132992
author Pulkkinen, Leena
Ukkola, Olavi
Kolehmainen, Marjukka
Uusitupa, Matti
author_facet Pulkkinen, Leena
Ukkola, Olavi
Kolehmainen, Marjukka
Uusitupa, Matti
author_sort Pulkkinen, Leena
collection PubMed
description Metabolic syndrome is a cluster of related risk factors for cardiovascular disease, type 2 diabetes and liver disease. Obesity, which has become a global public health problem, is one of the major risk factors for development of metabolic syndrome and type 2 diabetes. Obesity is a complex disease, caused by the interplay between environmental and genetic factors. Ghrelin is one of the circulating peptides, which stimulates appetite and regulates energy balance, and thus is one of the candidate genes for obesity and T2DM. During the last years both basic research and genetic association studies have revealed association between the ghrelin gene and obesity, metabolic syndrome or type 2 diabetes
format Text
id pubmed-2911592
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-29115922010-08-10 Ghrelin in Diabetes and Metabolic Syndrome Pulkkinen, Leena Ukkola, Olavi Kolehmainen, Marjukka Uusitupa, Matti Int J Pept Review Article Metabolic syndrome is a cluster of related risk factors for cardiovascular disease, type 2 diabetes and liver disease. Obesity, which has become a global public health problem, is one of the major risk factors for development of metabolic syndrome and type 2 diabetes. Obesity is a complex disease, caused by the interplay between environmental and genetic factors. Ghrelin is one of the circulating peptides, which stimulates appetite and regulates energy balance, and thus is one of the candidate genes for obesity and T2DM. During the last years both basic research and genetic association studies have revealed association between the ghrelin gene and obesity, metabolic syndrome or type 2 diabetes Hindawi Publishing Corporation 2010 2010-04-27 /pmc/articles/PMC2911592/ /pubmed/20700400 http://dx.doi.org/10.1155/2010/248948 Text en Copyright © 2010 Leena Pulkkinen et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Pulkkinen, Leena
Ukkola, Olavi
Kolehmainen, Marjukka
Uusitupa, Matti
Ghrelin in Diabetes and Metabolic Syndrome
title Ghrelin in Diabetes and Metabolic Syndrome
title_full Ghrelin in Diabetes and Metabolic Syndrome
title_fullStr Ghrelin in Diabetes and Metabolic Syndrome
title_full_unstemmed Ghrelin in Diabetes and Metabolic Syndrome
title_short Ghrelin in Diabetes and Metabolic Syndrome
title_sort ghrelin in diabetes and metabolic syndrome
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2911592/
https://www.ncbi.nlm.nih.gov/pubmed/20700400
http://dx.doi.org/10.1155/2010/248948
work_keys_str_mv AT pulkkinenleena ghrelinindiabetesandmetabolicsyndrome
AT ukkolaolavi ghrelinindiabetesandmetabolicsyndrome
AT kolehmainenmarjukka ghrelinindiabetesandmetabolicsyndrome
AT uusitupamatti ghrelinindiabetesandmetabolicsyndrome